US SB418 | 2019-2020 | 116th Congress
Status
Spectrum:
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.
Title
FDA Accountability for Public Safety Act
Sponsors
| Sen. Joe Manchin [D-WV] | Sen. Shelley Capito [R-WV] | Sen. Angus King [I-ME] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-02-07 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB5632 (Same As) 2020-01-16 - Referred to the House Committee on Energy and Commerce.
Subjects
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Federal officials
Food and Drug Administration (FDA)
Government ethics and transparency, public corruption
Health
Marketing and advertising
Prescription drugs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Federal officials
Food and Drug Administration (FDA)
Government ethics and transparency, public corruption
Health
Marketing and advertising
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/418/all-info |
| Text | https://www.congress.gov/116/bills/s418/BILLS-116s418is.pdf |
